Saint Kitts and Nevis vs Ukraine: Prevalence of hypertension, male
Saint Kitts and Nevis
45.1%
in 2019
Ukraine
44.5%
in 2019
Saint Kitts and Nevis rank
38th
Ukraine rank
41st
Prevalence of hypertension, male over time
- Saint Kitts and Nevis
- Ukraine
How they compare
Saint Kitts and Nevis currently reports 45.1% against 44.5% in Ukraine, a difference of 0.6%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Ukraine ahead.
Saint Kitts and Nevis ranks 38th and Ukraine ranks 41st of 192 countries.
Ukraine has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 40.8% | 51.6% | 10.9% | Ukraine |
| 2000s | 43.9% | 51.5% | 7.6% | Ukraine |
| 2010s | 45.2% | 47.4% | 2.2% | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Saint Kitts and Nevis or Ukraine?
- Saint Kitts and Nevis, at 45.1% against 44.5% in Ukraine as of 2019.
- What is the difference in prevalence of hypertension, male between Saint Kitts and Nevis and Ukraine?
- 0.6%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Ukraine?
- 30 years are reported by both, from 1990 to 2019.
- How do Saint Kitts and Nevis and Ukraine rank globally for prevalence of hypertension, male?
- Saint Kitts and Nevis ranks 38th and Ukraine ranks 41st of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.